Endobronchial post-transplant lymphoproliferative disorder and its management with photodynamic therapy: A case report

Journal of Heart and Lung Transplantation

Volumn 22, Issue 4, 2003, Pages 474-477

  Legere, Brian M ^a   Saad, Cynthia P ^b   Mehta, Atul C ^b  

^a Coastal Pulmonary Medicine ^*  (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTIBODY; AZATHIOPRINE; CD20 ANTIGEN; CYCLOSPORIN; GANCICLOVIR; HEMATOPORPHYRIN DERIVATIVE; INTERFERON; PREDNISONE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACUTE RESPIRATORY FAILURE; ADULT; ARGON LASER; ARTICLE; BRONCHOPLASTY; BRONCHOSCOPY; BRONCHUS DISEASE; BRONCHUS STENOSIS; CASE REPORT; ELECTROSURGERY; EPSTEIN BARR VIRUS; FOLLOW UP; GRAFT REJECTION; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; LUNG BIOPSY; LUNG FIBROSIS; LUNG INFECTION; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; NEODYMIUM LASER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 0037381464     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00821-5     Document Type: Article

References (26)

1. Swinnen L.J. Treatment of organ transplant-related lymphoma. Hematol Oncol Clin North Am. 11:1997;963-973.
2. Craig F.E., Gulley M.L., Banks P.M. Posttransplantation lymphoproliferative disorders. Am J Clin Pathol. 99:1993;265-276.
3. Basgoz N., Preiksaitis J.K. Post-transplant lymphoproliferative disorder. Infect Dis Clin North Am. 9:1995;901-923.
4. Cockfield S.M., Preiksaitis J., Harvey E., et al. Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lymphoproliferative disorder. Transplant Proc. 23:1991;1106-1107.
5. Swinnen L.J., Costanzo-Nordin M.R., Fisher S.G., et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med. 323:1990;1723-1728.
6. Opelz G., Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 342:1993;1514-1516.
7. Rappaport D.C., Chamberlain D.W., Shepherd F.A.Hutcheon M.A. Lymphoproliferative disorders after lung transplantation imaging features . Radiology. 206:1998;519-524.
8. Dodd G.D., Ledesma-Medina J., Baron R.L., Fuhrman C.R. Posttransplant lymphoproliferative disorder intrathoracic manifestations . Radiology. 184:1992;65-69.
9. Collins J., Muller N.L., Leung A.N., et al. Epstein-Barr-virus-associated lymphoproliferative disease of the lung CT and histologic findings . Radiology. 208:1998;749-759.
10. Hammer G.B., Cao S., Boltz M.G., et al. Post-transplant lymphoproliferative disease may present with severe airway obstruction. Anesthesiology. 89:1998;263-265.
11. Armitage J.M., Kormos R.L., Stuart S., et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients ten years of cyclosporine-based immunosuppression . J Heart Lung Transplant. 10:1991;877-886.
12. Faro A., Kurland G., Michaels M.G., et al. Interferon-alpha affects the immune response in post-transplant lymphoproliferative disorder. Am J Respir Crit Care Med. 153:1996;1442-1447.
13. Pirsch J.D., Stratta R.J., Sollinger H.W., et al. Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir two cases after solid organ transplantation . Am J Med. 86:1989;241-244.
14. Hanto D.W., Frizzera G., Gajl-Peczalska K., et al. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation . N Engl J Med. 306:1982;913-918.
15. Benkerrou M., Jais J.P., Leblond V., et al. Anti-B-cell monoclonal antibody treatment of severe posttransplant B- lymphoproliferative disorder prognostic factors and long-term outcome . Blood. 92:1998;3137-3147.
16. Maloney D.G., Grillo-Lopez A.J., White C.A., et al. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood. 90:1997;2188-2195.
17. Faye A., van Den Abeele T., Peuchmaur M., et al. Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders. Lancet. 352:1998;1285.
18. Oleinick N.L., Evans H.E. The photobiology of photodynamic therapy cellular targets and mechanisms . Radiat Res. 159:1998;S146-S146.
19. McCaughan J.S., Williams T.E. Photodynamic therapy for endobronchial malignant disease a prospective fourteen-year study . J Thorac Cardiovasc Surg. 114:1997;940-947.
20. Kavuru M.S., Mehta A.C., Eliachar I. Effect of photodynamic therapy and external beam radiation therapy on juvenile laryngotracheobronchial papillomatosis. Am Rev Respir Dis. 141:1990;509-510.
21. Shikowitz M.J., Abramson A.L., Freeman K., et al. Efficacy of DHE photodynamic therapy for respiratory papillomatosis immediate and long-term results . Laryngoscope. 108:1998;962-967.
22. Imamura S., Kusunoki Y., Takifuji N., et al. Photodynamic therapy and/or external beam radiation therapy for roentgenologically occult lung cancer. Cancer. 73:1993;1608-1614.
23. Sutedja T., Baas P., Stewart F., van Zandwijk N. A pilot study of photodynamic therapy in patients with inoperable non-small cell lung cancer. Eur J Cancer. 28A:1992;1370-1373.
24. LoCicero J.D., Metzdorff M., Almgren C. Photodynamic therapy in the palliation of late stage obstructing non-small cell lung cancer. Chest. 98:1990;97-100.
25. Mulroney C., Gluck S., Ho A.D. The use of photodynamic therapy in bone marrow purging. Semin Oncol. 21:1994;24-27.
26. Gulati S., Atzpodien J., Lemoli R.M., Shimazaki C., Clarkson B. Photoradiation methods for purging autologous bone marrow grafts. Prog Clin Biol Res. 333:1990;87-102.